Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas.
Eighty-nine primary lung carcinomas and 23 metastatic lung tumors were immunohistochemically studied for the expression of pulmonary surfactant apoproteins, by using monoclonal (PE-10) and polyclonal antibodies. Surfactant apoprotein was demonstrated in the cytoplasm and/or nuclear inclusion bodies of only primary lung adenocarcinomas (36 of 75 cases), not in any other histologic type of primary lung carcinoma or in metastatic lung tumors. In primary lung adenocarcinoma, although typical type II pneumocyte type adenocarcinoma was not included in the current series, the majority of surfactant apoprotein-positive single cell type tumors were of the Clara cell type, with a single bronchial surface epithelial cell type, according to the light microscopic subclassification of adenocarcinoma cells. The Clara cell type adenocarcinomas could at times be distinguished only with difficulty from adenocarcinoma of type II pneumocyte type. Normal and hyperplastic type II pneumocytes were of course positive for surfactant apoprotein in the cytoplasm. However, none of the positive cells could definitely be identified as Clara cells in non-neoplastic lungs. The findings obtained in this study indicate that surfactant apoprotein is a good marker to distinguish adenocarcinoma of the lung from other histologic types of lung cancer and from neoplasms metastatic to the lung, and that type II pneumocytes and Clara cells, non-neoplastic and neoplastic, are morphologically and functionally closely related and might belong to the same cell lineage.
Mizutani
Y
Y
Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.
Nakajima
T
T
Morinaga
S
S
Gotoh
M
M
Shimosato
Y
Y
Akino
T
T
Suzuki
A
A
D000230:Adenocarcinoma / Q000276:immunology* / Q000473:pathology / Q000556:secondary; D000911:Antibodies, Monoclonal / Q000276:immunology; D001053:Apolipoproteins / Q000032:analysis / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology / Q000556:secondary; D011663:Pulmonary Surfactants / Q000032:analysis / Q000276:immunology*
D000911:Antibodies, Monoclonal; D001053:Apolipoproteins; D011663:Pulmonary Surfactants